SGLT2-inhibitor: Empa 51% less heart failure hospitalization (EMPRISE). Cana kidney data 34% reduction (CREDENCE ) april 15, 2019 3:16 e m Läs mer »
Berzelius symposium Obesity and Type 2 Diabetes, understanding the role of ethnicity in Umeå the 11-12th of September 2019 april 15, 2019 1:03 e m Läs mer »
Så påverkar livsstilen våra gener. Charlotte Ling, Tina Rönn.Cell Metabolism april 14, 2019 6:32 e m Läs mer »
Barndiabetesfonden 30 years, Scientific Symposium Linköping, 17-18 October 2019 april 14, 2019 6:15 e m Läs mer »
Diabetespatienter med annan kulturell bakgrund – diabetessköterskans perspektiv. Sheyda Sofizadeh april 14, 2019 6:02 e m Läs mer »
SGLT-2 Inhibitor dapagliflozin (Forxiga) Approved for Adults with T1DM in Europe. ”A Milestone” april 10, 2019 4:56 f m Läs mer »
